When David Brent helped start the STAR Center at the Western Psychiatric Institute and Clinic 30 years ago, the field of youth suicide prevention “was scary,” he said.
“There were no real effective treatments for depression, either pharmacological or behavioral, and there were no good suicide intervention therapies,” he said about the research and clinical center that saw 360 patients over the last year alone. “But now there are some tools in your tool box you can go to for help. I’d say we’re in a much better place than when we started.”

The Services for Teens At Risk, or STAR, Center will mark its 30-year history as one of the first youth suicide prevention centers in the country this week with a two-day conference Wednesday and Thursday at the University Club in Oakland.
The conference will bring together 27 of the world’s most renowned suicide researchers from six countries, including the U.S., to talk to mental health professionals and primary care doctors about current cutting-edge technology.
But while these veteran researchers have all had success in creating new suicide risk diagnostic or assessment tools or therapies or treatments, they have all watched with dismay over the last decade as the youth suicide rate — and the overall rate — in the U.S. has steadily crept up after nearly two decades of steady decline.
“It is a concern,” said John Mann, a professor of translational neuroscience at Columbia University in New York, who will present on his work mapping the brains of people at-risk of suicide. “The U.S. suicide rate is up 27.3 percent since 2000 while most of the world has had a decline.”
“Forty-four thousand people a year [of any age in the U.S.] are now dying [from suicide] so we have a sense of urgency” to make progress with research, he said.
Dr. Brent shares that concern.
When he started the STAR Center in 1986, he said he “had a 10-year plan, and I think things went pretty much according to plan until the ‘black box’ warning.”
In 2004, the U.S. Food and Drug Administration placed stricter warnings on packaging on some of the anti-depression drugs prescribed to youths after some studies found that they led to a slightly higher risk of suicide.
Dr. Brent and many researchers and clinicians believe those drugs helped reduce the suicide rate until then. But as more doctors prescribed fewer of those anti-depressants, the suicide rate began rising, though researchers believe there are reasons beyond medication issues.
According to U.S. Centers for Disease Control and Prevention data, after reaching a recent low of 3.87 deaths per 100,000 people in 2007, the suicide rate for 10-19-year-olds has risen every year since, reaching 5.92 deaths per 100,000 people in 2015, the last year data is available. That is the highest suicide rate for that age group since 1995.
That’s despite the fact that suicide is more deeply researched than it has ever been, said Dr. Mann, who recently completed a review of all the published research on suicide prevention methods.
Among new strategies to be presented at the conference will be an interactive questionnaire that uses a few select questions to help assess if a person is at-risk for suicide. It was developed by Robert Gibbons, director of health statistics at the University of Chicago, in collaboration with Dr. Brent.
“What we’ve shown is with roughly 10 items and about 2 minutes we can extract the same conclusions that a highly trained clinician could reach in a half-hour interview about a person’s suicide risk,” Mr. Gibbons said. “That is if there were enough trained clinicians to go around.”
A version of the interactive questionnaire for adults is already in use in Veterans’ Affairs hospitals, schools and jails. The youth version is still being validated and the team hopes to have it in use soon, he said.
Also presenting at the conference will be Lisa Pan, a psychiatrist and researcher at the STAR Center since 2002, who will talk about her ongoing work on detecting possible metabolic abnormalities in patients with previously untreatable depression.
Her work has drawn attention globally because it may provide direct diagnosis and help to a group of patients — about 15 of all people diagnosed with depression — for whom existing therapies have not worked. Some of these patients can fully recover from their depression by replacing the missing metabolites, her research shows.
After she received nearly $2 million in funding last year from several families and foundations, she began recruiting possible patients: “We were supposed to recruit 90 people in three years, but we recruited 90 in eight months.”
It is the kind of research that Dr. Brent said is why he helped found the STAR Center in the first place.
“I am very proud of what we have accomplished,” he said. “But we just still have a long way to go.”
Sean D. Hamill: shamill@post-gazette.com or 412-263-2579 or Twitter: @SeanDHamill





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.